At Johnson & Johnson, we have an unrelenting vision to ease the tremendous global burden of cardiovascular disease. From anticoagulation, to advanced mapping and catheter ablation to treat atrial fibrillation, to cutting-edge technology that enables heart recovery through temporarily assisting the pumping function of the heart, to next generation investigational antithrombotics with the potential to help address unmet needs in acute coronary syndrome and stroke, our medical technologies and therapeutics are helping treat some of the most prevalent heart conditions, driving better outcomes and lasting impact for patients.